These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 11164755)
1. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Drevets WC; Gautier C; Price JC; Kupfer DJ; Kinahan PE; Grace AA; Price JL; Mathis CA Biol Psychiatry; 2001 Jan; 49(2):81-96. PubMed ID: 11164755 [TBL] [Abstract][Full Text] [Related]
2. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Drevets WC; Price JC; Kupfer DJ; Kinahan PE; Lopresti B; Holt D; Mathis C Neuropsychopharmacology; 1999 Dec; 21(6):694-709. PubMed ID: 10633475 [TBL] [Abstract][Full Text] [Related]
3. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Oswald LM; Wong DF; McCaul M; Zhou Y; Kuwabara H; Choi L; Brasic J; Wand GS Neuropsychopharmacology; 2005 Apr; 30(4):821-32. PubMed ID: 15702139 [TBL] [Abstract][Full Text] [Related]
4. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults. Oswald LM; Wand GS; Wong DF; Brown CH; Kuwabara H; Brašić JR Neuroimage; 2015 Jun; 113():26-36. PubMed ID: 25795343 [TBL] [Abstract][Full Text] [Related]
5. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. Martinez D; Slifstein M; Broft A; Mawlawi O; Hwang DR; Huang Y; Cooper T; Kegeles L; Zarahn E; Abi-Dargham A; Haber SN; Laruelle M J Cereb Blood Flow Metab; 2003 Mar; 23(3):285-300. PubMed ID: 12621304 [TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Riccardi P; Li R; Ansari MS; Zald D; Park S; Dawant B; Anderson S; Doop M; Woodward N; Schoenberg E; Schmidt D; Baldwin R; Kessler R Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395 [TBL] [Abstract][Full Text] [Related]
7. Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and Low-Avoidance Rats. Bellés L; Dimiziani A; Tsartsalis S; Millet P; Herrmann FR; Ginovart N Int J Neuropsychopharmacol; 2021 Mar; 24(3):239-251. PubMed ID: 33151278 [TBL] [Abstract][Full Text] [Related]
8. Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: modulation by MAO-inhibition. Pedersen K; Simonsen M; Østergaard SD; Munk OL; Rosa-Neto P; Olsen AK; Jensen SB; Møller A; Cumming P Neuroimage; 2007 Mar; 35(1):38-46. PubMed ID: 17223363 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. Ren J; Xu H; Choi JK; Jenkins BG; Chen YI Synapse; 2009 Sep; 63(9):764-72. PubMed ID: 19484725 [TBL] [Abstract][Full Text] [Related]
10. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans. Kegeles LS; Zea-Ponce Y; Abi-Dargham A; Rodenhiser J; Wang T; Weiss R; Van Heertum RL; Mann JJ; Laruelle M Synapse; 1999 Mar; 31(4):302-8. PubMed ID: 10051112 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study. Ceccarini J; Koole M; Van Laere K Addict Biol; 2022 May; 27(3):e13167. PubMed ID: 35470551 [TBL] [Abstract][Full Text] [Related]
12. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974 [TBL] [Abstract][Full Text] [Related]
14. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release. McCormick PN; Ginovart N; Wilson AA Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481 [TBL] [Abstract][Full Text] [Related]
15. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Breier A; Adler CM; Weisenfeld N; Su TP; Elman I; Picken L; Malhotra AK; Pickar D Synapse; 1998 Jun; 29(2):142-7. PubMed ID: 9593104 [TBL] [Abstract][Full Text] [Related]
20. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Abi-Dargham A; van de Giessen E; Slifstein M; Kegeles LS; Laruelle M Biol Psychiatry; 2009 Jun; 65(12):1091-3. PubMed ID: 19167701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]